HUTCHMED (China) Limited
IPOPublic · Hong Kong, Hong Kong · Founded 2000 · $100.0M raised
- Headquarters
- Hong Kong
- Employees
- 1001–5000
- Founded
- 2000
- Business Model
- B2B
- Website
- hutch-med.com
- Total Funding
- $100.0M
- Last Round
- $100.0M Private EquityJan 2013
- Rounds
- 1
- Type
- Public
About
Innovative commercial-stage biopharmaceutical company discovering and developing targeted therapies for cancer and immunological diseases.
Summary
HUTCHMED (China) Limited is a Biotech company based in Hong Kong, Hong Kong, founded in 2000. It has raised $100.0M in total across 1 round, most recently a $100.0M Private Equity round in Jan 2013. Investors include Baring Private Equity, Canada Pension Plan Investment Board and The Carlyle Group.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2021
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...